Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Cash (2019 - 2025)

Goldenwell Biotech filings provide 7 years of Change in Cash readings, the most recent being -$30885.0 for Q3 2025.

  • On a quarterly basis, Change in Cash fell 47.32% to -$30885.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $40867.0, a 670.45% increase, with the full-year FY2024 number at -$3827.0, down 152.9% from a year prior.
  • Change in Cash hit -$30885.0 in Q3 2025 for Goldenwell Biotech, down from $59380.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $59380.0 in Q2 2025 to a low of -$145655.0 in Q1 2022.
  • Median Change in Cash over the past 5 years was -$12090.0 (2022), compared with a mean of -$8419.2.
  • Biggest five-year swings in Change in Cash: soared 14130.99% in 2021 and later crashed 1410.15% in 2024.
  • Goldenwell Biotech's Change in Cash stood at -$19373.0 in 2021, then soared by 37.59% to -$12090.0 in 2022, then skyrocketed by 441.7% to $41312.0 in 2023, then increased by 8.08% to $44649.0 in 2024, then crashed by 169.17% to -$30885.0 in 2025.
  • The last three reported values for Change in Cash were -$30885.0 (Q3 2025), $59380.0 (Q2 2025), and -$32277.0 (Q1 2025) per Business Quant data.